Printer Friendly
The Free Library
14,635,740 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Zacks Bull and Bear of the Day Highlights: Southern Copper, Amylin Pharmaceuticals, Regis and Smith International.


CHICAGO -- Zacks Equity Research highlights Southern Copper (NYSE NYSE

See: New York Stock Exchange
: PCU PCU - PCI Configuration Utility ) as the Bull of the Day and Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. Currently, Amylin produces two drugs, Symlin (pramlintide acetate) and Byetta (exenatide). Amylin also is working on producing a drug based on Leptin.  (Nasdaq: AMLN) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Regis (NYSE: RGS RGS Royal Geographical Society
RGS Rio Grande do Sul (Brazilian State)
RGS Regulators of G Protein Signaling
RGS Royal Grammar School (England)
RGS Royal Grammar School (UK) 
) and Smith International (NYSE: SII SII Servicio de Impuestos Internos (Chile)
SII Seiko Instruments, Inc.
SII Strong Interest Inventory
SII Standards Institution of Israel
SII Securities and Investment Institute (UK) 
). Full analysis of all four stocks is available at http://at.zacks.com/?id=2676.

Here is a synopsis of all four stocks:

Bull of the Day:

Our Bull of the Day recommendation is for Southern Copper (NYSE: PCU). We have a positive outlook on Southern Copper's profit picture based on the favorable global demand for copper. We think the company is well positioned to expand production amidst higher grade ores at its mines. Further, the company has undertaken various exploration projects, which will enhance the production capacity, once operational. This, in conjunction with high copper prices, provides a favorable backdrop for revenue. Based on these positive fundamental factors, we continue to reiterate the Buy rating with a six-month target price of $121.00.

Bear of the Day:

Our Bear of the Day recommendation is for Amylin Pharmaceuticals (Nasdaq: AMLN), which is engaged in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes, obesity and cardiovascular diseases. The top-line is being driven by sales of two diabetes drugs, Byetta and Symlin. Sales of both drugs were lower than expected in the most recent quarter due to heavy sampling and increased competition. We think the competitive landscape is only getting worse for Amylin, and despite the fact that we are enthusiastic about the early-to-mid stage pipeline, we feel the name is overvalued Overvalued

A stock whose current price is not justified by the earnings outlook or price/earnings (P/E) ratio and thus, expected to drop in price. Overvaluation may result from an emotional buying spurt, which inflates the market price of the stock or from a deterioration in a
. Amylin trades at 45x our 2010 EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format.  estimate of $0.95. This is a significant premium to the peer group. We would avoid the name. Our target is $36.

Analyst Blog:

We maintain our Hold rating on shares of Regis (NYSE: RGS). With RGS currently generating only modest growth, we do not believe that a significant upward move in the stock price is warranted at this time. Regis has an excellent platform and is unquestionably un·ques·tion·a·ble  
adj.
Beyond question or doubt. See Synonyms at authentic.



un·question·a·bil
 the dominant player in this space, and as such could post considerable improvements in operating results should fashion trends move in its favor. We believe that investors will have time to react to such a move, however, and therefore, we rate the shares a Hold. The company will report full fourth quarter financial results on August 22, and we will update our model and outlook at that time.

Smith International's (NYSE: SII) second-quarter 2007 results came in weaker than expected, reflecting seasonal drilling slowdown and weather-related project delays in Canada. Revenue increased 26% year over year and 3% sequentially on the back of strong results from international offshore markets. Lower Canadian activity resulted in the loss of high-margin product sales during the quarter. Excluding the Canadian operations, sequential revenue and earnings gains were 6% and 11%, respectively. Outside North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , revenue increased 9% sequentially and 33% year over year, driven by gains across all the segments.

Get the full analysis of all four stocks by going to http://at.zacks.com/?id=2649.

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day In Business, the trading day is the time span that a particular stock exchange is open. For example, the New York Stock Exchange is, as of 2006, open from 09:30AM to 4:00PM. Trading days never take place on weekends. , the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis Qualitative Analysis

Securities analysis that uses subjective judgment based on nonquantifiable information, such as management expertise, industry cycles, strength of research and development, and labor relations.
 to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day"
subscribe, take

buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company";
 this free newsletter today by visiting http://at.zacks.com/?id=2677.

About Zacks

Zacks.com is a property of Zacks Investment Research Zacks Investment Research

A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms.
, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros by going to http://at.zacks.com/?id=2650.

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Zacks Rank performance is the total return (price changes + dividends) of equal weighted portfolios, consisting of those stocks with the indicated Zacks Rank, assuming zero transaction costs Transaction Costs

Costs incurred when buying or selling securities. These include brokers' commissions and spreads (the difference between the price the dealer paid for a security and the price they can sell it).
. These returns are not the result of a backtest; these are actual returns since 1988. The stocks in the Zacks Rank portfolios were available to Zacks clients before the beginning of each month (monthly rebalancing Rebalancing

The process of realigning the weightings of one's portfolio of assets.

Notes:
For example, if your portfolio's proportion of stock has grown too large for your intended assets weightings and risk tolerance, you might rebalance by selling some stock and putting
). Performance results from 1988 through September 2006 are based on a subset of all Zacks Rank stocks that excludes stocks covered by only one analyst and ADR's.

The S&P 500 Index is a well-known, unmanaged index of the prices of 500 large-company common stocks, mainly blue-chip stocks, selected by Standard & Poor's. The S&P 500 Index assumes reinvestment Reinvestment

Using dividends, interest and capital gains earned in an investment or mutual fund to purchase additional shares or units, rather than receiving the distributions in cash.

1. In terms of stocks, it is the reinvestment of dividends to purchase additional shares.
 of dividends but does not reflect advisory fees. An investor cannot invest directly in an index.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 25, 2007
Words:1019
Previous Article:Zacks Analyst Interview Highlights: Hewlett-Packard, Opsware, IBM and Computer Associates.
Next Article:Archstone-Smith to Release Second Quarter 2007 Financial Results.(Financial report)
Topics:



Related Articles
Mr. Smith takes a stand.(Editorials)(Oregon's Republican senator is right on Iraq)(Editorial)
Porter's time well-spent.(Sports)(The UO guard might not be playing as much as he would like, but he says he has grown during a trip to Serbia)
No kidding: These tots can shop.(General News)(Springfield's annual children's flea market attracts a crowd of aspiring bargain hunters and...
Florence mayor faces recall petition.(General News)(People behind the effort to oust Phil Brubaker accuse him of bungling a condominum project and...
FOR THE RECORD.(Vitals)
BRIEFLY.(Fires)(METRO)
OBITUARIES.(Vitals)
BRIEFLY.(Festivals)(WILD CARD)
TO OUR READERS:.(LA.COM)
Honor roll donors support future service.(Honors)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles